HIV

HIV Drug Study Highlights Difference In Kidney, Liver Risks Between Older and Newer Gilead Drugs

By
1 Mins read
126
0
Share
Reading Time: < 1 minute

FOSTER CITY, CALIFORNIA – MARCH 24: Biotechnology company Gilead is photographed at the company headquarters in Foster City, Calif., Wednesday, March 25, 2020. (Karl Mondon/Bay Area News Group)

As Gilead faces thousands of HIV drug lawsuits over side effects of Truvada, Viread and other TDF-based medications,  Read More

126
0
Share
Related posts
HIV

US approves life-saving organ transplants between people with HIV, removing ‘unnecessary barriers’

By
1 Mins read
Reading Time: < 1 minute People with HIV who need liver and kidney transplants can now receive organs from donors with HIV. Read More
HIV

'Huge relief' as new drug found to effectively prevent HIV infection

By
1 Mins read
Reading Time: < 1 minute A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published research from the pivotal…
HIV

HIV warning issued by UKHSA as diagnosis rate jumps by more than 30%

By
1 Mins read
Reading Time: < 1 minute Startling new data warns that HIV cases may be on the rise in England, serving as a ‘crucial reminder’ that we must safeguard…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.